Gram-stained Bacillus subtilis
Sporulating Bacillus subtilis
Bacillus subtilis, known also as the hay bacillus or grass bacillus, is a Gram-positive, catalase-positive bacterium. A member of the genus Bacillus, B. subtilis is rod-shaped, and has the ability to form a tough, protective endospore, allowing the organism to tolerate extreme environmental conditions. Unlike several other well-known species, B. subtilis has historically been classified as an obligate aerobe, though recent research has demonstrated that this is not strictly correct.
Although this species is commonly found in soil, more evidence are suggesting that B. subtilis is a normal gut commensal in humans. Recent study compared the number of spores carried by the soil (~10 6 spores/g) versus the levels found in human feces (~10 4 spores/g). The number of spores found in the human gut is too high to be attributed solely to consumption through food contamination. Soil simply serves as a reservoir, suggesting that B. subtilis inhabits the gut and should be considered as a normal gut commensal.
B. subtilis is only known to cause disease in severely immunocompromised patients, and can conversely be used as a probiotic in healthy individuals. It rarely causes food poisoning. which are clearly associated with the presence of emetic and diarrheal toxines. Some B. subtilis strains produce the proteolytic enzyme subtilisin. B. subtilis spores can survive the extreme heat during cooking. Some B. subtilis strains are responsible for causing ropiness a sticky, stringy consistency caused by bacterial production of long-chain polysaccharides in spoiled bread dough. For a long time, bread ropiness was associated uniquely with B. subtilis specie by biochemical tests. Today, molecular assays (randomly amplified polymorphic DNA PCR assay, denaturing gradient gel electrophoresis analysis, and sequencing of the V3 region of 16S ribosomal DNA) revealed greater Bacillus species variety in ropy breads which all seems to have a positive amylase activity and high heat resistance.
The Bacillus subtilis microbial strain and substances derived from this microorganism were subjects of evaluation by different authoritative bodies for their safe and beneficial use in food and has been regarded as not presenting safety concerns. Indeed, in United States an opinion letters issued in the early 1960s, the Food and Drug Administration (FDA) recognized as GRAS some substances derived from microorganisms, including carbohydrase and protease enzymes from Bacillus subtilis. The opinions are predicated on the use of non-pathogenic and non-toxicogenic strains of the respective organism and on the use of current good manufacturing practice (FDA partial list of microorganisms, 2002)
FDA stated that non-toxigenic and non-pathogenic strains of B. subtilis are widely available and have been safely used in a variety of food applications, including the documented consumption of B. subtilis in the Japanese fermented soy bean, natto. FDA concluded that the enzymes derived from the B. subtilis strain were in common use in food prior to January 1st, 1958. Natto, which is commonly consumed in Japan, contains as many as 108 viable B. subtilis/gram. The natto fermented beans are recognized for their contribution to a healthy gut flora and vitamin K2 intake; during this long history of widespread use natto has no been implicated in any adverse events potentially attributable to the presence of B. subtilis.
The unic strain of ''Bacillus subtilis'' R0179 which is genetically comparable to the natto, received the non-novel status in Canada based on history of consumption meaning that this specific strain can safely be used as a probiotic to conventional foods. The strain R0179 also received the self-affirmed GRAS status in January 2012.
The natto product and the Bacillus subtilis natto as its principal component are FOSHU approved in Japan. The Foods for Specified Health Use (FOSHU) are the foods approved by the Ministry of Health, Labor and Welfare as effective for preservation of health by adding certain active ingredients or removing undesirable ones. They are designed to be safe and effective for the maintenance and improvement of health by incorporating them into one s diet. The Japanese FOSHU products are products the safety and efficacy of which have been verified scientifically.
The Association of American Feed Control Officials (AAFCO) has listed Bacillus subtilis approved for use as a feed ingredient under Section 36.14 Direct-Fed Microorganisms. This microorganism was reviewed by the Food and Drug administration Center for Veterinary medicine and found to present no safety concerns when used in direct-fed microbial products. The Canadian Food Inspection Agency (CFIA)-Animal health and production Feed Section has classified Bacillus culture dehydrated approved feed ingredients as a silage additive under Schedule IV-Part 2-Class 8.6 and assigned the International Feed Ingredient number IFN 8-19-119.
The Bacillus subtilis species has a long history of safe use. It has been granted Qualified Presumption of Safety (QPS) status by the European Food Safety Authority (EFSA) and is part of the authoritative list of microorganisms with a documented history of safe use in food established by the International Dairy Federation (IDF) in collaboration with the European Food and Feed Cultures Association (EFFCA) in 2002 and updated in 2012.
B. subtilis can divide symmetrically to make two daughter cells (binary fission), or asymmetrically, producing a single endospore that can remain viable for decades and is resistant to unfavourable environmental conditions such as drought, salinity, extreme pH, radiation and solvents. The endospore is formed at times of nutritional stress, allowing the organism to persist in the environment until conditions become favorable. Prior to the process of sporulation the cells might become motile by producing flagella, take up DNA from the environment, or produce antibiotics. These responses are viewed as attempts to seek out nutrients by seeking a more favourable environment, enabling the cell to make use of new beneficial genetic material or simply by killing of competition.
B. subtilis is a model organism used to study bacterial chromosome replication. Replication of the single circular chromosome initiates at a single locus, the origin (oriC). Replication proceeds bidirectionally and two replication forks progress in clockwise and counterclockwise directions along the chromosome. Chromosome replication is completed when the forks reach the terminus region, which is positioned opposite to the origin on the chromosome map. The terminus region contains several short DNA sequences (Ter sites) that promote replication arrest. Specific proteins mediate all the steps in DNA replication. Comparison between the proteins involved in chromosomal DNA replication in B. subtilis and in Escherichia coli reveals similarities and differences. Although the basic components promoting initiation, elongation, and termination of replication are well-conserved, some important differences can be found (such as one bacterium missing proteins essential in the other). These differences underline the diversity in the mechanisms and strategies that various bacterial species have adopted to carry out the duplication of their genomes.
B. subtilis has proven highly amenable to genetic manipulation, and has become widely adopted as a model organism for laboratory studies, especially of sporulation, which is a simplified example of cellular differentiation. It is also heavily flagellated, which gives B. subtilis the ability to move quickly in liquids. In terms of popularity as a laboratory model organism, B. subtilis is often used as the Gram-positive equivalent of Escherichia coli, an extensively studied Gram-negative bacterium.
Wild-type natural isolates of B. subtilis are difficult to work with compared to laboratory strains that have undergone domestication processes of mutagenesis and selection. These strains often have improved capabilities of transformation (uptake and integration of environmental DNA), growth, and loss of abilities needed "in the wild." And, while dozens of different strains fitting this description exist, the strain designated 168 is the most widely used.
B. subtilis is commonly used as a model organism in laboratory studies directed at discovering the fundamental properties and characteristics of Gram-positive spore-forming bacteria . In particular, the basic principles and mechanisms underlying formation of the durable endospore have been deduced from studies of spore formation in B. subtilis.
Colonies of B. subtilis grown on a culture dish in a molecular biology laboratory.
In addition to its role as a model organism, B. subtilis is used as a soil inoculant in horticulture and agriculture.
The high stability of B. subtilis in harsh environmental conditions makes this microorganism a perfect candidate for probiotics applications either in baked and pasteurized foods/beverages or in other galienic forms like tablets, capsules and powder. The strain Bacillus subtilis R0179 is well-documented for its probiotic benefices.
B. globigii, a closely related but phylogenetically distinct species now known as B. atrophaeus  was used as a biowarfare simulant during Project SHAD (aka Project 112).. Subsequent genomic analysis showed that the strains used in those studies were products of deliberate enrichment for strains that exhibited abnormally high rates of sporulation .
Enzymes produced by B. subtilis and B. licheniformis are widely used as additives in laundry detergents.
Its other uses include:
- A strain of B. subtilis formerly known as Bacillus natto is used in the commercial production of the Japanese food natto, as well as the similar Korean food cheonggukjang.
B. subtilis strain QST 713 (marketed as QST 713 or Serenade) has a natural fungicidal activity, and is employed as a biological control agent.
- It was popular worldwide before the introduction of consumer antibiotics as an immunostimulatory agent to aid treatment of gastrointestinal and urinary tract diseases. It is still widely used in Western Europe and the Middle East as an alternative medicine
- It can convert (decompose) some explosives into harmless compounds of nitrogen, carbon dioxide, and water.
- Its surface binding properties play a role in safe radionuclide waste [e.g. thorium (IV) and plutonium (IV)] disposal.
- Recombinant strains pBE2C1 and pBE2C1AB were used in production of polyhydroxyalkanoates (PHA), and malt waste can be used as their carbon source for lower cost PHA production.
- It is used to produce amylase.
- It is used to produce hyaluronic acid, which is useful in the joint-care sector in healthcare.
- It may provide some benefit to saffron growers by speeding corm growth and increasing stigma biomass yield.
B. subtilis has approximately 4,100 genes. Of these, only 192 were shown to be indispensable; another 79 were predicted to be essential as well. A vast majority of essential genes were categorized in relatively few domains of cell metabolism, with about half involved in information processing, one-fifth involved in the synthesis of cell envelope and the determination of cell shape and division, and one-tenth related to cell energetics.
Several non-coding RNAs have been characterized in the B. subtilis genome, including Bsr RNAs.
In 1835, the bacterium was originally named Vibrio subtilis by Christian Gottfried Ehrenberg, and renamed Bacillus subtilis by Ferdinand Cohn in 1872. Cultures of B. subtilis were used throughout the 1950s as an alternative medicine due to the immunostimulatory effects of its cell matter, which upon digestion has been found to significantly stimulate broad spectrum immune activity including activation of specific antibody IgM, IgG and IgA secretion and release of CpG dinucleotides inducing INF A/Y producing activity of leukocytes and cytokines important in the development of cytotoxicity towards tumor cells. It was marketed throughout America and Europe from 1946 as an immunostimulatory aid in the treatment of gut and urinary tract diseases such as Rotavirus and Shigella, but declined in popularity after the introduction of cheap consumer antibiotics, despite causing less chance of allergic reaction and significantly lower toxicity to normal gut flora.
- Adenylosuccinate lyase deficiency
- Guthrie test
ar: ca:Bacillus subtilis de:Bacillus subtilis es:Bacillus subtilis fr:Bacillus subtilis it:Bacillus subtilis he:Bacillus subtilis hu:Bacillus subtilis nl:Bacillus subtilis ja: pl:Laseczka sienna pt:Bacillus subtilis ru: simple:Bacillus subtilis sk:Bacillus subtilis sv:Bacillus subtilis tr:Bacillus subtilis uk:Bacillus subtilis zh: